BioCube, Inc.
BICB
$0.00
$0.000.00%
OTC PK
| 07/31/2013 | 04/30/2013 | 01/31/2013 | 10/31/2012 | 07/31/2012 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 50.20K | 45.30K | 127.90K | 84.50K | 129.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.20K | 45.30K | 127.90K | 84.50K | 129.60K |
| Operating Income | -50.20K | -45.30K | -127.90K | -84.50K | -129.60K |
| Income Before Tax | -75.80K | -184.30K | -280.00K | -374.00K | -65.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -75.80K | -184.30K | -280.00K | -374.00K | -65.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.80K | -184.30K | -280.00K | -374.00K | -65.10K |
| EBIT | -50.20K | -45.30K | -127.90K | -84.50K | -129.60K |
| EBITDA | -50.20K | 102.20K | -55.50K | -58.80K | -103.80K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 48.78M | 48.78M | 30.90M | 32.09M | 32.38M |
| Average Diluted Shares Outstanding | 48.78M | 48.78M | 30.90M | 32.09M | 32.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |